top of page
Writing on tablet

Scientific Writing Services

At Viginovix, we believe that scientific writing is more than just documentation—it’s about translating complex scientific data into clear, concise, and regulatory-compliant reports that support drug development and patient safety. Whether it’s a clinical study report, an informed consent form, or an FDA IND safety submission, our team of experienced medical writers ensures that every document is accurate, structured, and aligned with global regulatory standards.

​

We work closely with pharmaceutical companies, biotech firms, and clinical research organizations (CROs) to deliver high-quality, regulatory-compliant scientific documents that drive successful submissions and approvals. Our expertise spans across clinical trials, regulatory filings, and post-marketing surveillance, ensuring that your scientific writing needs are covered at every stage of development.

Our Scientific Writing Services

            Aggregate Reports: Comprehensive Safety and Efficacy Summaries

​

Aggregate reports provide a holistic view of drug safety and efficacy by compiling data from multiple sources. Our expert team prepares well-structured, regulatory-compliant reports that support decision-making and regulatory approvals.

​

  • Development Safety Update Reports (DSURs)

  • Periodic Benefit-Risk Evaluation Reports (PBRERs)

  • Periodic Safety Update Reports (PSURs)

  • Annual Safety Reports (ASRs) for clinical trials

​

"Clear, data-driven reporting ensures transparency in drug safety and supports regulatory compliance."

            Clinical Development Plan: Roadmap for Drug Development

​

A well-structured Clinical Development Plan (CDP) serves as a blueprint for a drug’s journey from discovery to market approval. Our experts develop strategic, evidence-based CDPs that align with regulatory expectations.

​

  • Comprehensive planning of clinical trials from Phase I to Phase IV

  • Integration of non-clinical, clinical, and regulatory strategies

  • Risk-benefit assessment and regulatory guidance alignment

  • Detailed timeline for drug development milestones​​

​

"A strong clinical development plan lays the foundation for a successful drug approval process."

            Clinical Study Report (CSR): Presenting Trial Results with Precision

​

A Clinical Study Report (CSR) is a critical document that summarizes a clinical trial’s objectives, methodology, results, and conclusions. At Viginovix, we ensure that your CSRs meet ICH E3 guidelines, providing a clear and comprehensive overview of your study findings.

​

  • Structured and regulatory-compliant reporting of clinical trial data

  • In-depth statistical analysis and interpretation of study results

  • Concise yet detailed narratives for regulatory submissions

  • Seamless integration with CTD Module 5 requirements

​

"Your trial’s success depends on how well its results are communicated. We help ensure clarity, accuracy, and compliance."

           Clinical Study Protocol: Defining the Study’s Success

​

A Clinical Study Protocol serves as the foundation for a well-executed trial. Our expert writers develop clear, regulatory-compliant protocols that ensure seamless study execution.

​

  • Development of Phase I-IV clinical trial protocols

  • Inclusion of study design, methodology, objectives, and endpoints

  • Alignment with ICH, FDA, and EMA guidelines

  • Integration of ethical and safety considerations

​

"A well-defined protocol ensures a smooth trial, regulatory approval, and reliable results."

            Common Technical Document (CTD): Streamlining Regulatory Submissions

​

The Common Technical Document (CTD) is the backbone of regulatory submissions, ensuring a standardized approach across different agencies. Our expert writers compile CTD modules with precision and regulatory alignment to support successful drug approvals.

​

  • Preparation of CTD Modules 2 (Summary) and 5 (Clinical Study Reports)

  • Regulatory-compliant formatting for FDA, EMA, MHRA, and PMDA

  • Seamless integration of non-clinical and clinical data

  • Well-structured dossiers for INDs, NDAs, and MAAs

​

"Regulatory approval is built on well-structured documentation—our CTDs ensure seamless submissions."

            Informed Consent Form: Ensuring Ethical Transparency

​

An Informed Consent Form (ICF) is more than a regulatory requirement—it is a patient’s right to understand a clinical trial before participation. Our ICFs are clear, concise, and compliant, ensuring transparency and patient comprehension.

​

  • Layman-friendly language for easy understanding

  • Compliance with ethical and regulatory guidelines (ICH-GCP, FDA, EMA)

  • Clear explanation of study risks, benefits, and procedures

  • Ethically sound content that meets IRB and Ethics Committee requirements

​

"Informed patients make empowered decisions. We ensure clarity and compliance in every consent form."

            Investigator’s Brochure (IB): A Comprehensive Guide for Researchers

​

The Investigator’s Brochure (IB) is a critical document that provides clinical investigators with key safety and efficacy information about an investigational drug. We ensure that your IB is detailed, scientifically accurate, and fully compliant with regulatory standards.

​

  • Compilation of preclinical and clinical data on investigational products

  • Regulatory-compliant format based on ICH E6 guidelines

  • Detailed safety and risk assessment for investigators

  • Regular updates based on emerging clinical data

​

"Investigators rely on accurate data to conduct safe trials. We ensure your IB is comprehensive and up to date."

            Clinical Evaluation Report (CER): Essential for Medical Device Approvals

​

A Clinical Evaluation Report (CER) is a crucial part of medical device regulation, ensuring that the product meets safety and performance standards. Our team prepares robust, evidence-based CERs that align with EU MDR (Medical Device Regulation) requirements.

​

  • Comprehensive literature reviews and clinical data analysis

  • Risk-benefit assessment based on real-world evidence

  • Compliance with EU MDR 2017/745 guidelines

  • Well-structured documentation for Notified Body submission

​

"A well-prepared CER ensures regulatory approval and patient safety for medical devices."

            FDA IND Safety Reporting: Ensuring Compliance in Early-Stage Drug Development

​

For companies submitting an Investigational New Drug (IND) application, timely and accurate safety reporting is essential. Our team ensures that your FDA IND safety reports are prepared in compliance with 21 CFR 312.32 requirements.

​

  • Preparation of IND Annual Safety Reports and Expedited Reports

  • Timely submission of Serious Adverse Event (SAE) reports

  • Regulatory compliance with FDA IND safety reporting requirements

  • Clear, data-driven narratives for risk assessment

​

"Accurate and timely safety reporting is key to keeping investigational drugs on track for approval."

Why Choose Viginovix for Scientific Writing Services?

Regulatory Excellence – We ensure 100% compliance with FDA, EMA, MHRA, and global pharmacovigilance regulations.

Industry Experts – Our highly skilled medical professionals, PV specialists, and regulatory experts handle cases with precision and expertise.

Tailored Solutions – Whether you're a startup biotech or a global pharmaceutical leader, we customize our ICSR services to fit your specific needs.

24/7 Compliance Support – Our team is always available to ensure timely submissions and real-time case tracking.

"Pharmacovigilance isn’t just about compliance—it’s about protecting lives. At Viginovix, we take that responsibility seriously."

Get in touch today to streamline your ICSR management and ensure global compliance.

bottom of page